{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:57:55Z","timestamp":1778014675323,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.yebeh.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T13:20:01Z","timestamp":1313587201000},"page":"200-206","source":"Crossref","is-referenced-by-count":39,"title":["The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Leila","family":"Moezi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Hojati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad R.","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2011.07.002_bb0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199701163360306","article-title":"Melatonin in humans","volume":"336","author":"Brzezinski","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/074873049701200617","article-title":"Commentary: evidence for melatonin as a circadian phase-shifting agent","volume":"12","author":"Czeisler","year":"1997","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-079X.1995.tb00171.x","article-title":"Cell protective role of melatonin in the brain","volume":"19","author":"Acuna-Castroviejo","year":"1995","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/8062","article-title":"Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors","volume":"2","author":"Wan","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0149-7634(95)00052-6","article-title":"Melatonin effects on behavior: possible mediation by the central GABAergic system","volume":"20","author":"Golombek","year":"1996","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.1993.tb00503.x","article-title":"Melatonin and sleep in humans","volume":"15","author":"Dawson","year":"1993","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0028-3908(81)90043-5","article-title":"The anticonvulsant properties of melatonin on kindled seizures in rats","volume":"20","author":"Albertson","year":"1981","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(98)00790-3","article-title":"Anticonvulsant effects of melatonin in amygdala-kindled rats","volume":"257","author":"Mevissen","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0924-977X(98)00022-4","article-title":"Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice","volume":"9","author":"Borowicz","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-079X.1996.tb00243.x","article-title":"Acute and chronic effects of melatonin as an anticonvulsant in male gerbils","volume":"20","author":"Champney","year":"1996","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1358\/mf.2004.26.3.809723","article-title":"Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures","volume":"26","author":"Ray","year":"2004","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1600-079X.2003.00055.x","article-title":"Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures","volume":"35","author":"Bikjdaouene","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0361-9230(90)90080-J","article-title":"GABA as a presumptive paracrine signal in the pineal gland: evidence on an intrapineal GABAergic system","volume":"25","author":"Rosenstein","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1528-1157.1995.tb01669.x","article-title":"Melatonin response in active epilepsy","volume":"36","author":"Schapel","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-1781(94)90073-6","article-title":"Day\u2013night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children","volume":"52","author":"Molina-Carballo","year":"1994","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.1997.tb00341.x","article-title":"Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience","volume":"23","author":"Molina-Carballo","year":"1997","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pediatrneurol.2009.11.002","article-title":"Melatonin and sleep-related problems in children with intractable epilepsy","volume":"42","author":"Elkhayat","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0090","first-page":"CR389","article-title":"Melatonin and childhood refractory epilepsy: a pilot study","volume":"16","author":"Paprocka","year":"2010","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(95)00669-9","article-title":"Modulation of opioid analgesia by agmatine","volume":"296","author":"Kolesnikov","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0893-133X(00)00245-1","article-title":"Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice","volume":"25","author":"Yesilyurt","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0110","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0024-3205(97)00801-1","article-title":"Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats","volume":"61","author":"Aricioglu-Kartal","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0091-3057(02)00774-8","article-title":"Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats","volume":"72","author":"Morgan","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0120","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.97.19.10584","article-title":"Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury","volume":"97","author":"Fairbanks","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1476-5381.1996.tb15726.x","article-title":"Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery","volume":"119","author":"Gonzalez","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(96)00274-9","article-title":"Functional properties of agmatine in rat vas deferens","volume":"307","author":"Jurkiewicz","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0028-3908(03)00199-0","article-title":"Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide","volume":"45","author":"Demehri","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-3057(02)01079-1","article-title":"An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine","volume":"74","author":"Bence","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2003.11.016","article-title":"Anticonvulsive effect of agmatine in mice","volume":"77","author":"Su","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1734-1140(09)70029-5","article-title":"Influence of agmatine on the protective action of numerous antiepileptic drugs against pentetrazole-induced seizures in mice","volume":"61","author":"Luszczki","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eplepsyres.2005.09.057","article-title":"Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice","volume":"68","author":"Yahyavi-Firouz-Abadi","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.eplepsyres.2007.05.002","article-title":"Melatonin enhances the anticonvulsant and proconvulsant effects of morphine in mice: role for nitric oxide signaling pathway","volume":"75","author":"Yahyavi-Firouz-Abadi","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0165","first-page":"122","article-title":"Evaluation of the role of melatonin in formalin-induced pain response in mice","volume":"58","author":"Ray","year":"2004","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-079X.2009.00703.x","article-title":"Therapeutic potential of melatonin in traumatic central nervous system injury","volume":"47","author":"Samantaray","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0180","first-page":"187","article-title":"Neuroprotective effects of receptor imidazoline 2 and its endogenous ligand agmatine","volume":"22","author":"Qiu","year":"2006","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0185","doi-asserted-by":"crossref","first-page":"C1411","DOI":"10.1152\/ajpcell.00529.2008","article-title":"The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis","volume":"296","author":"Arndt","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.057","article-title":"Anxiolytic effect of agmatine in rats and mice","volume":"550","author":"Gong","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0200","first-page":"2629","article-title":"Antiepileptic drugs: detection, quantification, and evaluation","volume":"44","author":"Swinyard","year":"1985","journal-title":"Fed Proc"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: III. Pentylenetetrazole seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004691-199204010-00007","article-title":"Subcortical structures and pathways involved in convulsive seizure generation","volume":"9","author":"Gale","year":"1992","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(96)01496-5","article-title":"L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice","volume":"753","author":"Kaputlu","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-079X.1998.tb00535.x","article-title":"Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice","volume":"24","author":"Lapin","year":"1998","journal-title":"J Pineal Res"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/088307389801301007","article-title":"Melatonin's role as an anticonvulsant and neuronal protector: experimental and clinical evidence","volume":"13","author":"Munoz-Hoyos","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0165-6147(00)88978-6","article-title":"Melatonin receptors: are there multiple subtypes?","volume":"16","author":"Dubocovich","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0197-0186(94)90100-7","article-title":"Melatonin receptors: localization, molecular pharmacology and physiological significance","volume":"24","author":"Morgan","year":"1994","journal-title":"Neurochem Int"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0248-4900(98)80009-9","article-title":"Melatonin receptor pharmacology: toward subtype specificity","volume":"89","author":"Sugden","year":"1997","journal-title":"Biol Cell"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0047-6374(01)00384-0","article-title":"Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin","volume":"123","author":"Reiter","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0250","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1196\/annals.1403.021","article-title":"Effect of luzindole and other melatonin receptor antagonists on iron- and lipopolysaccharide-induced lipid peroxidation in vitro","volume":"1122","author":"Requintina","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yebeh.2009.07.022","article-title":"Anticonvulsant effects of the selective melatonin receptor agonist ramelteon","volume":"16","author":"Fenoglio-Simeone","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.0013-9580.2005.30204.x","article-title":"Hippocampal melatonin receptors modulate seizure threshold","volume":"46","author":"Stewart","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0091-3057(90)90395-X","article-title":"Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors","volume":"36","author":"Derlet","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-3565(25)32193-2","article-title":"Noradrenergic influences on sound-induced seizures","volume":"214","author":"Horton","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(81)90348-4","article-title":"Alpha-noradrenaline modulation of D, L-allylgycine seizures","volume":"75","author":"Ashton","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-1838(98)00091-5","article-title":"Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain","volume":"72","author":"Reis","year":"1998","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1304.001","article-title":"Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress","volume":"1009","author":"Halaris","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1196\/annals.1304.015","article-title":"Effect of agmatine on electrically and chemically induced seizures in mice","volume":"1009","author":"Aricioglu","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2011.07.002_bb0295","article-title":"Rang and Dale's Pharmacology","author":"Rang","year":"2007"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011003866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011003866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T21:38:15Z","timestamp":1741469895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505011003866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1525505011003866"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.07.002","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}